Key Educational Points: Emphasize the experimental nature No clinical trials support this combination Highlight individual compound efficacy Both peptides show strong effects as monotherapies Discuss approved alternatives CagriSema and other studied combinations offer evidence-based options Explain regulatory status Neither compound has FDA approval for metabolic applications as of 2026 Address safety concerns Overlapping side effect profiles create legitimate risks When clients express interest in research peptides, directing them toward compounds with established safety profiles and dosing protocols serves their best interests
For years, many widely-used peptides sat in Category 2 not because of safety failures, but because the FDA's review process lagged behind clinical demand and real-world use
Pregnant or breastfeeding patients should consult a doctor before receiving IV therapy
Reprod Sci 30(8):244956 Golinska M, Rycerz A, Sobczak M, Chrzanowski J, Stawiski K, Fendler W (2025) Complement and coagulation cascade cross-talk in endometriosis and the potential of Janus Kinase inhibitors-a network metaanalysis
Overall, IV glutathione therapy is commonly used as part of a comprehensive wellness approach to improve cellular function and promote overall health and vitality
For now, any decision to use GHK-Cu injections should be made with full awareness of the current knowledge and limitations